Clinical trial
Identification of Acute Intermittent Porphyria Modifying Genes
Identification of Acute Intermittent Porphyria Modifying Genes
ClinicalTrials.gov ID: NCT05502133
Sponsor: Icahn School of Medicine at Mount Sinai
Information provided by: Robert Desnick, Icahn School of Medicine at Mount Sinai (Responsible Party)
Last Update Posted: 2023-04-14
Brief Summary:
This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porphyria (AIP), an autosomal dominant inborn error of heme biosynthesis.
Official Title:
Identification of Acute Intermittent Porphyria Modifying Genes
| Category | Value |
|---|---|
| Study Start (Actual) | 2022-09-23 |
| Primary Completion (Estimated) |
2024-03
|
| Study Completion (Estimated) | 2024-03 |
| Enrollment (Estimated) | 150 |
| Study Type | Observational |
| Other Study ID Numbers |
GCO 18-1800 |